Literature DB >> 30402839

MiR-128-3p overexpression sensitizes hepatocellular carcinoma cells to sorafenib induced apoptosis through regulating DJ-1.

X-L Guo1, H-B Wang, J-K Yong, J Zhong, Q-H Li.   

Abstract

OBJECTIVE: DJ-1 expression is elevated in a variety of tumors and is related to the survival of tumor cells under adverse stimuli. DJ-1 3'-untranslated region (3'-UTR) contains the target of miR-128-3p, and the expression of miR-128-3p is decreased in hepatoma cells. Therefore, we speculate and address in this study, that miR-128-3p can regulate DJ-1 expression in hepatocellular carcinoma (HCC) and play an important role in HCC cells survival.
MATERIALS AND METHODS: MiR-128-3p and DJ-1 expression in HCC cell lines were measured using quantitative Real Time-Polymerase Chain Reaction (qRT-PCR) and Western blot analysis. Dual luciferase reporter assay was adopted to confirm the miR-128-3p binding sequences in the 3'-UTR of DJ-1. Sorafenib-induced apoptosis was evaluated by flow cytometry, and the apoptosis-associated proteins were detected by Western blot analysis. Overexpression of miR-128-3p and DJ-1 were achieved via transfection with miR-128-3p mimic and DJ-1 plasmid, respectively.
RESULTS: We revealed that miR-128-3p expression was downregulated, while DJ-1 expression was upregulated in HCC cell lines, and DJ-1 expression can be regulated by miR-128-3p via directly binding to it. Moreover, functional assays showed that overexpression of miR-128-3p sensitized HCC cells to sorafenib-induced apoptosis, and this phenomenon was partly abolished by DJ-1. Mechanistically, PTEN/PI3K/Akt signaling pathway was found to participate in the miR-128-3p induced sensitivity to sorafenib via DJ-1.
CONCLUSIONS: We conclude that miR-128-3p overexpression sensitized HCC to sorafenib-induced apoptosis via PTEN/PI3K/Akt signaling pathway by regulating DJ-1 expression.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30402839     DOI: 10.26355/eurrev_201810_16143

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  10 in total

Review 1.  Moving beyond the Tip of the Iceberg: DJ-1 Implications in Cancer Metabolism.

Authors:  Erika Olivo; Marina La Chimia; Jessica Ceramella; Alessia Catalano; Ferdinando Chiaradonna; Maria Stefania Sinicropi; Giovanni Cuda; Domenico Iacopetta; Domenica Scumaci
Journal:  Cells       Date:  2022-04-23       Impact factor: 7.666

2.  ZNRD1-AS1 knockdown alleviates malignant phenotype of retinoblastoma through miR-128-3p/BMI1 axis.

Authors:  Guanghua Yang; Chen Zeng; Yang Liu; Dongliang Li; Juanjuan Cui
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

3.  SCAMP3 is regulated by miR-128-3p and promotes the metastasis of hepatocellular carcinoma cells through EGFR-MAPK p38 signaling pathway.

Authors:  Le Kang; Ze-Hua Zhang; Ying Zhao
Journal:  Am J Transl Res       Date:  2020-12-15       Impact factor: 4.060

Review 4.  Novel Insights into PARK7 (DJ-1), a Potential Anti-Cancer Therapeutic Target, and Implications for Cancer Progression.

Authors:  Wook Jin
Journal:  J Clin Med       Date:  2020-04-26       Impact factor: 4.241

5.  Lnc-SNHG16/miR-128 axis modulates malignant phenotype through WNT/β-catenin pathway in cervical cancer cells.

Authors:  Wu Wu; Li Guo; Zhenlong Liang; Yuanbin Liu; Zhi Yao
Journal:  J Cancer       Date:  2020-02-03       Impact factor: 4.207

Review 6.  Roles of Thyroid Hormone-Associated microRNAs Affecting Oxidative Stress in Human Hepatocellular Carcinoma.

Authors:  Po-Shuan Huang; Chia-Siu Wang; Chau-Ting Yeh; Kwang-Huei Lin
Journal:  Int J Mol Sci       Date:  2019-10-21       Impact factor: 5.923

7.  miR-128-3p serves as an oncogenic microRNA in osteosarcoma cells by downregulating ZC3H12D.

Authors:  Maoshu Zhu; Yulong Wu; Zhaowei Wang; Minghua Lin; Bin Su; Chunyang Li; Fulong Liang; Xinjiang Chen
Journal:  Oncol Lett       Date:  2020-12-31       Impact factor: 2.967

8.  MicroRNA-128-3p Mediates Lenvatinib Resistance of Hepatocellular Carcinoma Cells by Downregulating c-Met.

Authors:  Xin Xu; Wenjing Jiang; Peng Han; Jingyan Zhang; Liquan Tong; Xueying Sun
Journal:  J Hepatocell Carcinoma       Date:  2022-02-27

Review 9.  PARK7/DJ-1 as a Therapeutic Target in Gut-Brain Axis Diseases.

Authors:  Domonkos Pap; Apor Veres-Székely; Beáta Szebeni; Ádám Vannay
Journal:  Int J Mol Sci       Date:  2022-06-14       Impact factor: 6.208

10.  Nanocomplexes loaded with miR-128-3p for enhancing chemotherapy effect of colorectal cancer through dual-targeting silence the activity of PI3K/AKT and MEK/ERK pathway.

Authors:  Xin Liu; Chao Dong; Siping Ma; Yongpeng Wang; Tao Lin; Yanxi Li; Shihua Yang; Wanchuan Zhang; Rui Zhang; Guohua Zhao
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.